| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 6.59B | 4.65B | 5.67B | 10.01B | 10.39B |
| Gross Profit | 407.95M | 311.68M | 441.46M | 1.09B | 989.95M |
| EBITDA | 166.97M | 153.95M | 189.30M | 558.05M | 542.68M |
| Net Income | 160.90M | 100.34M | 71.13M | 164.74M | 214.06M |
Balance Sheet | |||||
| Total Assets | 2.26B | 1.69B | 1.74B | 2.86B | 3.64B |
| Cash, Cash Equivalents and Short-Term Investments | 336.64M | 297.72M | 395.28M | 494.40M | 290.93M |
| Total Debt | 593.89M | 315.68M | 484.46M | 1.05B | 1.67B |
| Total Liabilities | 1.20B | 734.14M | 835.88M | 1.66B | 2.60B |
| Stockholders Equity | 1.06B | 959.33M | 904.74M | 873.37M | 805.99M |
Cash Flow | |||||
| Free Cash Flow | -379.14M | 215.36M | 355.83M | 859.24M | -447.51M |
| Operating Cash Flow | -378.46M | 216.49M | 361.65M | 869.75M | -441.23M |
| Investing Cash Flow | 915.00K | 33.25M | 27.93M | -74.70M | -281.13M |
| Financing Cash Flow | 273.08M | -173.44M | -711.51M | -592.78M | 775.02M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$3.29B | 5.07 | 18.01% | 8.89% | 10.01% | 11.08% | |
67 Neutral | HK$517.02M | 1.25 | 5.41% | 0.98% | 6.90% | -55.59% | |
63 Neutral | HK$1.25B | 1.42 | 3.40% | 4.94% | 17.39% | -55.26% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | HK$1.38B | 6.04 | 15.86% | 6.74% | 41.79% | 62.77% | |
60 Neutral | HK$3.61B | 13.38 | 5.16% | ― | 50.32% | -1.54% | |
56 Neutral | HK$510.68M | 6.65 | 20.37% | ― | 87.51% | 901.59% |